Betta Pharmaceuticals Market Cap

Betta Pharmaceuticals has a market cap or net worth of 20.83 billion as of April 28, 2026. Its market cap has decreased by -2.82% in one year.

Market Cap

20.83B

Enterprise Value

22.95B

Revenue

3.73B

Ranking

n/a

PE Ratio

47.07

Stock Price

49.52

Market Cap Chart

Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 20.83B, an increase of 105.36%. That is a compound annual growth rate of 7.89%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	20.83B	6.06%
Dec 31, 2025	19.64B	-12.96%
Dec 31, 2024	22.57B	4.62%
Dec 29, 2023	21.57B	5.11%
Dec 30, 2022	20.53B	-38.09%
Dec 31, 2021	33.15B	-25.26%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Nov 7, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	22.23B
Jiangsu Nhwa Pharmaceutical Co., LTD	22.08B
Tasly Pharmaceutical Group	21.84B
Wedge Industrial	21.20B
Jilin Aodong Pharmaceutical Group	20.81B
Apeloa Pharmaceutical Co.,Ltd	20.66B
Joincare Pharmaceutical Group Industry	19.33B
Hybio Pharmaceutical	19.20B

Market Cap Rankings